Identification and validation of an immune-related miRNA signature for predicting prognosis of hepatocellular carcinoma

被引:0
作者
Hu, Tao [1 ]
Gu, Jiarong [2 ,3 ]
Tan, Lin [1 ]
Deng, Haiyan [3 ]
Gao, Xianxian [3 ]
Yang, Shanru [3 ]
Xu, Hao [3 ]
Hou, Xin [1 ,3 ]
Liao, Qi [3 ]
Yang, Xiaoping [1 ]
机构
[1] Ningbo Univ, Dept Hepatopancreatobiliary Surg, Affiliated Hosp 1, Ningbo 315010, Zhejiang, Peoples R China
[2] Ningxia Med Univ, Sch Publ Hlth, Yinchuan, Ningxia, Peoples R China
[3] Ningbo Univ, Hlth Sci Ctr, Ningbo 315211, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
microRNAs; Hepatocellular carcinoma; Prognosis; Immune cells; MIGRATION; INVASION;
D O I
10.1016/j.intimp.2024.113850
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MicroRNAs play a significant role in the initiation and progression of hepatocellular carcinoma (HCC); however, their roles in immune regulation of HCC remain unclear. Our study aimed to identify an immune-related miRNA signature and explore its impact on the prognosis and tumor immune microenvironment HCC. Initially, we identified 48 differentially expressed immune-related miRNAs. Using the LASSO regression dimensionality reduction method, we constructed an immune-related miRNA signature from 12 of these miRNAs. This signature has emerged as an independent prognostic marker and is associated with the clinical stage of HCC. To elucidate the roles of the twelve-microRNA signature, we predicted their target genes. Enrichment analysis indicated that these target genes were involved in immune cell infiltration. Notably, the target genes regulated by hsa-miR-1395p, hsa-miR-551a, and hsa-miR-7-5p showed a partial overlap. We further confirmed the differential expression of miR-7, miR-551a, miR-139-5p, and some of their overlapping target genes in tumor and non-tumor tissues derived from patients with HCC using RT-qPCR. Overall, we identified an immune-related miRNA signature that is strongly correlated with the prognosis and immune microenvironment of HCC; and confirmed the differential expression of the three most important microRNAs and their overlapping target genes in tumor and non-tumor tissues derived from HCC patients.
引用
收藏
页数:14
相关论文
共 31 条
  • [1] Brouillet A., 2023, eGastroenterology, V1
  • [2] Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma
    Calderaro, Julien
    Seraphin, Tobias Paul
    Luedde, Tom
    Simon, Tracey G.
    [J]. JOURNAL OF HEPATOLOGY, 2022, 76 (06) : 1348 - 1361
  • [3] miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin
    Chen, Wen-Shu
    Yen, Chia-Jui
    Chen, Yun-Ju
    Chen, Jhen-Yu
    Wang, Li-Yun
    Chiu, Shu-Jun
    Shih, Wen-Ling
    Ho, Chien-Yi
    Wei, Tzu-Tang
    Pan, Hsiao-Lin
    Chien, Pei-Hsuan
    Hung, Mien-Chie
    Chen, Ching-Chow
    Huang, Wei-Chien
    [J]. ONCOTARGET, 2015, 6 (28) : 25962 - 25974
  • [4] Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
    Chen, Yuqiao
    Tang, Lu
    Huang, Wentao
    Abisola, Fakolade Hannah
    Zhang, Youyu
    Zhang, Gewen
    Yao, Lei
    [J]. BIOLOGY DIRECT, 2023, 18 (01)
  • [5] Chen ZT, 2022, AM J TRANSL RES, V14, P3610
  • [6] Tumor-associated macrophages in liver cancer: From mechanisms to therapy
    Cheng, Kun
    Cai, Ning
    Zhu, Jinghan
    Yang, Xing
    Liang, Huifang
    Zhang, Wanguang
    [J]. CANCER COMMUNICATIONS, 2022, 42 (11) : 1112 - 1140
  • [7] The biology of human natural killer-cell subsets
    Cooper, MA
    Fehniger, TA
    Caligiuri, MA
    [J]. TRENDS IN IMMUNOLOGY, 2001, 22 (11) : 633 - 640
  • [8] Upregulated microRNA-132 in T helper 17 cells activates hepatic stellate cells to promote hepatocellular carcinoma cell migration in vitro
    Feng, Rui
    Cui, Zilin
    Liu, Zirong
    Zhang, Yamin
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 93 (05)
  • [9] Emerging immunotherapy or HCC: A guide for hepatologists
    Foerster, Friedrich
    Gairing, Simon Johannes
    Ilyas, Sumera Irie
    Galle, Peter Robert
    [J]. HEPATOLOGY, 2022, 75 (06) : 1604 - 1626
  • [10] BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma
    Fukushi, Daisuke
    Shibuya-Takahashi, Rie
    Mochizuki, Mai
    Fujimori, Haruna
    Kogure, Takayuki
    Sugai, Takahiro
    Iwai, Wataru
    Wakui, Yuta
    Abue, Makoto
    Murakami, Kazuhiro
    Nakamura, Yasuhiro
    Yasuda, Jun
    Yamaguchi, Kazunori
    Sugamura, Kazuo
    Shibata, Chikashi
    Katayose, Yu
    Satoh, Kennichi
    Tamai, Keiichi
    [J]. CANCER SCIENCE, 2021, 112 (11) : 4580 - 4592